20 Jun Guide to Neurofeedback Therapy
Posted at 12:47h
in Mental Health Research
The pandemic may be over, but its effects linger. According to a paper on the psychological impact of COVID-19 on...
23 Mar Prior studies claiming to find a lethal cannabis-immunotherapy drug interaction riddled with errors
Medical marijuana is a controversial topic. Some previous researchers have confused correlation with causation. A clear example of this is the “gateway” model of a sequence in drug use from readily available substances like alcohol and cigarettes, to marijuana, and later to heroin.
09 Aug Epigenetic Approach to Pediatric and Adult Brain Tumors
MedicalResearch.com Interview with: Sibaji Sarkar, Ph.D. Division of Biotech, Quincy College Quincy MA. Biology/STEM MBC College, Wellesley MA, Boston MA....
07 Aug Ovarian Cancer: Proteomics Study Allows Identification of Subtype Resistant to Chemotherapy
Posted at 14:18h
in Author Interviews, Biomarkers, Cancer Research, Genetic Research, Ovarian Cancer
MedicalResearch.com Interview with: Pei Wang, PhD Professor, Department of Genetics and Genomic Sciences Icahn School of Medicine at Mount Sinai,...
18 Apr AACR23: Phase 1 trial of IO-108, an antagonist antibody targeting LILRB2 (ILT4), as monotherapy and in combination with pembrolizumab in adult patients with advanced relapsed or refractory solid tumors
MedicalResearch.com Interview with: Matthew H. Taylor, MD Earle A. Chiles Research Institute Providence Cancer Institute Portland, OR MedicalResearch.com: What is...
03 Apr Alzheimer’s Disease: Long Gap Between Menopause and Hormone Therapy Might Raise Tau Burden
Posted at 21:27h
in Alzheimer's - Dementia, Author Interviews, Brigham & Women's - Harvard, Gender Differences, JAMA, Menopause
MedicalResearch.com Interview with: Rachel Buckley, PhD Assistant Professor Department of Neurology Massachusetts General Hospital/Harvard Medical School MedicalResearch.com: What is the...
22 Mar UT Southwestern Lab Studies Interaction of Gut Microbiota and Cancer Immunotherapy
Posted at 20:43h
in Author Interviews, Cancer Research, Immunotherapy, Melanoma, Science, UT Southwestern
MedicalResearch.com Interview with: Andrew Y. Koh, M.D. Associate Professor, Pediatrics and Microbiology University of Texas Southwestern Medical Center Director of...
17 Mar Smartphone Communicates Genetic Risk, Potentially Enhancing Compliance with Heart Medications
Communication of polygenic risk for coronary artery disease can drive the initiation of lipid lowering therapy in individuals who receive the greater risk-reduction benefits.
15 Mar Sleep Apnea Accelerates Aging – CPAP Therapy May Help Slow it Down
MedicalResearch.com Interview with: Rene Cortese, PhD Assistant Professor Department of Child Health – Child Health Research Institute Department of Obstetrics,...
03 Jan Prostate Cancer: Comparison of Outcomes for Black and White Men Treated with Radiation Therapy
Engaging Black men and increasing the representation of the Black population in cancer prevention and treatment studies should be a priority.
07 Nov Study of Fruit Flies Identifies Novel Human Obesity Genes
Obesity is an organism-level disorder that affects multiple organs and perturbs inter-organ communication.
11 Jul Pets Can Pass Genes for Antibiotic Resistance to Human Infections
We studied a large panel of antimicrobials besides Colistin, and we found evidence of sharing of the mcr-1 colistin resistance gene harbored by the similar multidrug resistant Escherichia coli clone colonizing the GI tract of both a dog with a skin infection and his owner.
23 Apr Mesothelioma: Prognostic Signature of 48 Genes Identified
We identify a 48-gene mesothelioma prognostic signature whose expression is highly predictive of patient survival. Some of these genes could be potential drug targets in treating malignant mesothelioma patients
22 Feb Glioblastoma: Inovio’s Novel Combination of DNA Medication Plus Immunotherapy Boosts Survival
Posted at 16:02h
in Author Interviews, Brain Cancer - Brain Tumors, Cancer Research, Immunotherapy, Pharmaceutical Companies
This is a first-of-its-kind clinical trial in which a DNA medicine encoding for tumor-specific antigens is combined with an immune checkpoint inhibitor, and given together with the standard of care, in patients with newly diagnosed glioblastoma.
05 Feb Identifying Cardiac Strain Early May Minimize Heart Failure in Chemotherapy Patients
The primary outcome was a comparison of change in heart function between pre-cancer treatment and 1 year later measured using LVEF.
17 Dec Icahn Researchers Find Cancer Immunotherapy Improved When Bystander Cells Killed
A common type of resistance to cancer immunotherapy (Antigen Escape) can likely be prevented.
05 Dec LENVIMA® (lenvatinib) Based Combination Therapy in Patients With Renal Cell Carcinoma
The study, in which 343 patients received LENVIMA plus everolimus, helps to contribute to the growing body of evidence supporting the role of this TKI-mTOR combination in the advanced RCC treatment paradigm.
03 Dec Hepato-Renal Syndrome Type 1: Treatment with Terlipressin Reduced Need for Renal Replacement Therapy
MedicalResearch.com Interview with: Khurram Jamil, MD Vice President, Clinical Research in Hepatology Critical Care Division, Mallinckrodt MedicalResearch.com: What is the...
22 Nov Rare Mutation in the PCSK9 Gene Confers Long Healthy Life
This study has utilized both clinical and biomedical approaches to better understand how a rare mutation in the PCSK9 gene can have a number of surprisingly protective effects on several different diseases.
07 Oct DetermaRx™ Stratification Test Identify Patients With Stage I-IIA Non-Squamous NSCLC Who May Benefit From Adjuvant Chemotherapy
DetermaRxTM is the only test available in lung cancer that can stratify patients based on their molecular risk of recurrence.
01 Oct Olaparib (Lynparza) Targeted Therapy for Metastatic Castration-Resistant Prostate Cancer
To understand the importance of these results, it is important to understand the patient population. Despite advances in treatment for men with metastatic castration-resistant prostate cancer, the disease continues to be very deadly and five-year survival remains low.
25 Sep Low Level Light Therapy Has Potential to Help Patients With Traumatic Brain Injury
On this small cohort of patients with acute moderate traumatic brain injury, we were able to demonstrate neuroreactivity in the patients who received light therapy.
20 Aug Tumor-Informed ctDNA Test Signatera Evaluates Immunotherapy Response Across Different Solid Tumors
The bespoke ctDNA test used in our study, Signatera, is customized to the unique genetic signature of a patient’s cancer.
30 Jul Wet AMD: Genentech’s Port Delivery System Can Allow Longer Intervals Between Ranibizumab Treatments
MedicalResearch.com Interview with: Carl D. Regillo, MD, FACS Chief, Retina Service Wills Eye Hospital MedicalResearch.com: What is the background for...
26 Jun Stage II Colon Cancer: Guardant Health Study Evaluates Predictive Value of Blood Biomarker in Adjuvant Chemotherapy
The NRG GI-005 trial is currently enrolling patients with low-risk stage IIA (T3N0) resected colon cancer across the United States, and has been activated in Canada as well.
01 Jun Photoaged Skin Therapy with Adipose-Derived Stem Cells
This study has demonstrated ADSC to remodeling the skin extra cellular matrix, mainly in the elastic system.
21 May Genes Linked to Melanoma of the Eye Identified
Though we don’t really understand why yet, there does seem to be a higher number of uveal melanoma cases in people with light colour irises.
19 May Metastatic Bladder Cancer: Study Evaluates Combination of Checkpoint Blocker with Chemotherapy
Response: This is the first randomized trial reporting results combining chemotherapy with immune checkpoint blockade in urothelial cancer versus chemotherapy alone or immune checkpoint blockade monotherapy versus chemotherapy.